• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

第十一届HIV药物不良反应与合并症国际研讨会的关键数据。

Key data from the 11th International Workshop on Adverse Drug Reactions and Co-Morbidities in HIV.

作者信息

Boehme Richard E, Cameron Stephen

机构信息

International Medical Press, Hamilton, NJ, USA.

出版信息

Antivir Ther. 2009;14(8):1195-208. doi: 10.3851/IMP1470.

DOI:10.3851/IMP1470
PMID:20032550
Abstract

The effectiveness of current antiretroviral therapies has led to more patients receiving long-term therapy, and increasing numbers of older patients. The complex interactions between HIV infection, ageing, comorbid conditions and drug-related toxicities, and their combined effects on patient health and quality of life, were the subject of the 11th International Workshop on Adverse Drug Reactions and Co-Morbidities in HIV. Key topics included the metabolic effects of antiretroviral agents, cardiovascular disease, bone metabolism and age-related changes in disease and response to drug therapy. Data presented at the meeting reflect the growing recognition of common pathways that contribute to progression of mutiple types of disease and adverse drug reactions.

摘要

目前抗逆转录病毒疗法的有效性使得更多患者接受长期治疗,老年患者的数量也在增加。HIV感染、衰老、合并症和药物相关毒性之间的复杂相互作用,以及它们对患者健康和生活质量的综合影响,是第11届HIV药物不良反应和合并症国际研讨会的主题。关键主题包括抗逆转录病毒药物的代谢影响、心血管疾病、骨代谢以及疾病的年龄相关变化和对药物治疗的反应。会议上展示的数据反映出人们越来越认识到导致多种疾病进展和药物不良反应的共同途径。

相似文献

1
Key data from the 11th International Workshop on Adverse Drug Reactions and Co-Morbidities in HIV.第十一届HIV药物不良反应与合并症国际研讨会的关键数据。
Antivir Ther. 2009;14(8):1195-208. doi: 10.3851/IMP1470.
2
Therapy insight: Body-shape changes and metabolic complications associated with HIV and highly active antiretroviral therapy.治疗洞察:与HIV及高效抗逆转录病毒治疗相关的体型变化和代谢并发症
Nat Clin Pract Endocrinol Metab. 2007 Sep;3(9):651-61. doi: 10.1038/ncpendmet0587.
3
Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.人类免疫缺陷病毒基因耐药性检测对治疗效果的影响研究。
Verh K Acad Geneeskd Belg. 2001;63(5):447-73.
4
Complications of HIV infection in an ageing population: challenges in managing older patients on long-term combination antiretroviral therapy.HIV 感染在老年人群体中的并发症:长期联合抗逆转录病毒治疗中老年患者管理面临的挑战。
J Antimicrob Chemother. 2011 Jun;66(6):1210-4. doi: 10.1093/jac/dkr058. Epub 2011 Mar 18.
5
Antiretroviral therapy: are we aware of adverse effects?抗逆转录病毒疗法:我们了解其不良反应吗?
J Assoc Physicians India. 2002 Sep;50:1163-71.
6
Beyond lipodystrophy: will toxicity issues ever outweigh the benefits of HAART?除脂肪代谢障碍外:毒性问题会否超过高效抗逆转录病毒治疗的益处?
J HIV Ther. 2003 May;8(2):27-8.
7
The metabolic puzzle during the evolution of HIV infection.HIV感染演变过程中的代谢谜题。
Clin Nutr. 2001 Oct;20(5):379-91. doi: 10.1054/clnu.2001.0429.
8
HIV infection and advanced age emerging epidemiological, clinical, and management issues.HIV感染与高龄:新出现的流行病学、临床及管理问题
Ageing Res Rev. 2004 Jan;3(1):31-54. doi: 10.1016/j.arr.2003.07.001.
9
The efficacy and adverse effects of GPO-VIR (stavudine+lamivudine+nevirapine) in treatment-naïve adult HIV patients.GPO-VIR(司他夫定+拉米夫定+奈韦拉平)在初治成年HIV患者中的疗效及不良反应。
Southeast Asian J Trop Med Public Health. 2005 Mar;36(2):362-9.
10
Toxicogenetics of antiretroviral therapy: genetic factors that contribute to metabolic complications.抗逆转录病毒疗法的毒理遗传学:导致代谢并发症的遗传因素。
Antivir Ther. 2007;12(7):999-1013.

引用本文的文献

1
Proximity of Cytomegalovirus-Specific CD8 T Cells to Replicative Senescence in Human Immunodeficiency Virus-Infected Individuals.人类免疫缺陷病毒感染个体中巨细胞病毒特异性 CD8 T 细胞与复制性衰老的接近程度。
Front Immunol. 2018 Feb 15;9:201. doi: 10.3389/fimmu.2018.00201. eCollection 2018.
2
Pharmacodynamics of PEG-IFN-[alpha]-2a and HCV response as a function of IL28B polymorphism in HIV/HCV-coinfected patients.聚乙二醇干扰素-α-2a 的药效学及 IL28B 多态性对 HIV/HCV 共感染患者 HCV 应答的影响。
J Acquir Immune Defic Syndr. 2011 Feb 1;56(2):95-9. doi: 10.1097/QAI.0b013e3182020596.
3
Very early prediction of response to HCV treatment with PEG-IFN-alfa-2a and ribavirin in HIV/HCV-coinfected patients.
在 HIV/HCV 合并感染患者中,用 PEG-IFN-alfa-2a 和利巴韦林进行 HCV 治疗的早期应答预测。
J Viral Hepat. 2011 Apr;18(4):e52-60. doi: 10.1111/j.1365-2893.2010.01358.x.